Ansabot, Emelyn .
HRN: 23-48-83 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/14/2024
CEFUROXIME 1.5GM (VIAL)
01/14/2024
01/21/2024
IVT
1.5 Gms
On Call To OR Then Q 8 Hrs
LTCS
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: PneumoniaReproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes